Gregory David

Gregory David, Ph.D.
Associate Professor, Department of Biochemistry and Molecular Pharmacology
Medical Science Building, Room 417
550 First Avenue, New York, NY10016
Office:  212-263-2926
Lab:  212-263-3035
EmailGregory.David@nyumc.org

KEY INTERESTS:
Transcription, Cancer, Chromatin, Mouse models, embryonic Stem Cells.

BIOGRAPHICAL DETAILS:

Graduate Education:  PhD in Genetics at Institut Pasteur (Paris) (1998)
Postdoctoral Training:  Dana-Farber Cancer Institute, Harvard Medical School (1999-2004)
Academic Appointments: 2004: Assistant Professor in Pharmacology
2011: Associate Professor in Pharmacology

Major Responsibilities: Co-Course Director

RESEARCH INTERESTS:
Our laboratory investigates the molecular events that underline cancer initiation and progression, especially as they relate to aberrant transcriptional regulation and chromatin modifications. We are using genetically engineered mouse models of human cancer, such as prostate and pancreatic cancer, to dissect the contribution of chromatin modifiers in the etiology of these diseases. In addition, our research also focuses on the function of specific chromatin modifiers in early cell fate decisions. We are currently addressing these questions using genetically engineered mouse embryonic stem cells, in combination with genome-wide approaches.

SELECTED PUBLICATIONS

LAB MEMBERS:
Gregory David, PhD (Principal Investigator)
Anthony Bainor (Graduate Student)
David Cantor (MD/PhD Student)
Lena Lau (Graduate Student)
Katarzyna Marcinkiewicz, PhD (Post-Doc)
Angelo Porciuncula, PhD (Post-Doc)
Chuan Zhi Foo (Master's Student)